000			02149 a2200565 4500
005			20250513231047.0
264		0	_c20010329
008			200103s 0 0 eng d
022			_a0363-6135
024	7		_a10.1152/ajpheart.2001.280.3.H1151 _2doi
040			_aNLM _beng _cNLM
100	1		_aHussain, M B
245	0	0	_aReciprocal regulation of cGMP-mediated vasorelaxation by soluble and particulate guanylate cyclases. _h[electronic resource]
260			_bAmerican journal of physiology. Heart and circulatory physiology _cMar 2001
300			_aH1151-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAorta _xphysiology
650	0	4	_aAtrial Natriuretic Factor _xmetabolism
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEnzyme Inhibitors _xpharmacology
650	0	4	_aGuanylate Cyclase _xmetabolism
650	0	4	_aHomeostasis _xphysiology
650	0	4	_aHumans
650	0	4	_aMammary Arteries _xphysiology
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aMuscle, Smooth, Vascular _xenzymology
650	0	4	_aNitric Oxide _xdeficiency
650	0	4	_aNitric Oxide Donors _xpharmacology
650	0	4	_aNitric Oxide Synthase _xgenetics
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aNitrogen Oxides
650	0	4	_aNitroglycerin _xpharmacology
650	0	4	_aPhenylephrine _xpharmacology
650	0	4	_aSolubility
650	0	4	_aSpermine _xanalogs & derivatives
650	0	4	_aVasoconstriction _xdrug effects
650	0	4	_aVasoconstrictor Agents _xpharmacology
650	0	4	_aVasodilation _xdrug effects
650	0	4	_aVasodilator Agents _xpharmacology
650	0	4	_aomega-N-Methylarginine _xpharmacology
700	1		_aMacAllister, R J
700	1		_aHobbs, A J
773	0		_tAmerican journal of physiology. Heart and circulatory physiology _gvol. 280 _gno. 3 _gp. H1151-9
856	4	0	_uhttps://doi.org/10.1152/ajpheart.2001.280.3.H1151 _zAvailable from publisher's website
999			_c11117424 _d11117424